Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

NovaBay Pharmaceuticals Inc (NYSE MKT LLC:NBY)

3.90
Delayed Data
As of 4:02pm ET
 +0.15 / +4.00%
Today’s Change
1.90
Today|||52-Week Range
5.29
+18.18%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Revenue and IncomeNet Revenues1.7M2.7M3.4M4.1M
 
 
 
 
 
Cost of Goods Sold571.0K452.0K535.0K808.0K
 
 
 
 
 
Depreciation And Amortization40.0K27.0K31.0K--
 
 
 
 
 
Operating ExpensesGross Income1.1M2.2M2.9M3.3M
 
 
 
 
 
General Expenses5.6M4.4M5.1M5.3M
 
 
 
 
 
Research And Development842.0K278.0K236.0K156.0K
 
 
 
 
 
Total Operating Expenses6.3M4.9M5.6M6.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.5M-2.2M-2.2M-2.0M
 
 
 
 
 
Extraordinary Credit0.000.000.00381.0K
 
 
Extraordinary Charge-476.0K-424.0K-1.7M--
 
 
 
 
Other Expenses-68.0K-59.0K180.0K1.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.1M-2.7M-3.7M-1.6M
 
 
 
 
 
Income Taxes0.00-2.0K0.000.00
 
 
Net Income-5.1M-2.7M-3.7M-1.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS4.1M7.4M10.9M15.1M
 
 
 
 
 
Shares To Calculate EPS Diluted4.1M7.4M10.9M15.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.24-$0.36-$0.34-$0.13
 
 
 
 
 
EPS Diluted-$1.24-$0.36-$0.34-$0.13